US Patent Issued to The Regents of the University of California on Aug. 25 for "Lentiviral vectors in hematopoietic stem cells to treat Wiskott-Aldrich syndrome (WAS)" (California Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,732, issued on Aug. 25, was assigned to The Regents of the University of California (Oakland, Calif.).

"Lentiviral vectors in hematopoietic stem cells to treat Wiskott-Aldrich syndrome (WAS)" was invented by Donald B. Kohn (Tarzana, Calif.), Ryan L. Wong (Los Angeles) and Roger Paul Hollis (Los Angeles).

According to the abstract* released by the U.S. Patent & Trademark Office: "In certain embodiments a lentiviral vector for the treatment of Wiskott-Aldrich Syndrome (WAS) is provided. In certain embodiments the vector comprises an expression cassette comprising a nucleic acid construct comprising an effective fragment of the endogenous promoter of the WAS gene where said promoter...